Geraniol protects against cyclophosphamide-induced hepatotoxicity in rats: Possible role of MAPK and PPAR-γ signaling pathways

Food Chem Toxicol. 2020 May:139:111251. doi: 10.1016/j.fct.2020.111251. Epub 2020 Mar 17.

Abstract

Cyclophosphamide (CP) is one of the famous anti-cancer drugs. However, CP-induced hepatotoxicity is a dose-limiting side effect. The present study aimed to investigate the potential protective effect of geraniol (GOH), the main ingredient of Palmarosa oil and rose oil, against CP-induced hepatotoxicity in rats. Results showed that CP provoked a marked elevation in serum levels of alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase. In addition, oxidative stress was significantly boosted in CP-treated rats as compared to control rats. On the other hand, GOH (200 mg/kg, p.o.) administration attenuated CP-evoked disturbances in the above-mentioned parameters. Moreover, histopathological aberrations in CP-treated rats were significantly ameliorated in GOH-treated rats. GOH markedly abrogated CP-induced inflammation via decreasing the protein expression of nuclear factor-kappa B, inducible nitric oxide synthase and cyclo-oxygenase 2, as well as reducing the levels of pro-inflammatory cytokines in CP-treated rats. CP induced activation of MAPK; p38 and JNK and diminished PPAR-γ protein expression. GOH effectively reversed all these effects. In conclusion, GOH is suggested to be a potential candidate for attenuation of CP-induced hepatotoxicity. This effect is attributed to its antioxidant and anti-inflammatory activities, as well as, modulation of MAPK and PPAR-γ signaling pathways.

Keywords: Cyclophosphamide; Geraniol; Hepatotoxicity; MAPK; PPAR-γ.

MeSH terms

  • Acyclic Monoterpenes / pharmacology*
  • Alanine Transaminase / blood
  • Alkaline Phosphatase / blood
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Antineoplastic Agents / toxicity
  • Antioxidants / pharmacology
  • Aspartate Aminotransferases / blood
  • Chemical and Drug Induced Liver Injury / drug therapy*
  • Chemical and Drug Induced Liver Injury / etiology
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism
  • Cyclophosphamide / toxicity*
  • Interleukin-1beta / blood
  • Liver / drug effects
  • Liver / metabolism
  • Male
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Nitric Oxide Synthase Type II / genetics
  • Nitric Oxide Synthase Type II / metabolism
  • Oils, Volatile / pharmacology
  • Oxidative Stress / drug effects
  • PPAR gamma / genetics*
  • PPAR gamma / metabolism
  • Protective Agents / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Tumor Necrosis Factor-alpha / blood
  • p38 Mitogen-Activated Protein Kinases / genetics*
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Acyclic Monoterpenes
  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Antioxidants
  • Interleukin-1beta
  • NF-kappa B
  • Oils, Volatile
  • PPAR gamma
  • Protective Agents
  • Tumor Necrosis Factor-alpha
  • Cyclophosphamide
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • Cyclooxygenase 2
  • Ptgs2 protein, rat
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • p38 Mitogen-Activated Protein Kinases
  • Alkaline Phosphatase
  • geraniol